Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Invested Capital (2021 - 2025)

Arcus Biosciences has reported Return on Invested Capital over the past 5 years, most recently at 0.64% for Q3 2025.

  • Quarterly results put Return on Invested Capital at 0.64% for Q3 2025, down 13.0% from a year ago — trailing twelve months through Sep 2025 was 0.64% (down 13.0% YoY), and the annual figure for FY2024 was 0.67%, down 5.0%.
  • Return on Invested Capital for Q3 2025 was 0.64% at Arcus Biosciences, down from 0.55% in the prior quarter.
  • Over the last five years, Return on Invested Capital for RCUS hit a ceiling of 0.1% in Q3 2022 and a floor of 0.79% in Q1 2025.
  • Median Return on Invested Capital over the past 5 years was 0.5% (2023), compared with a mean of 0.4%.
  • Biggest five-year swings in Return on Invested Capital: plummeted -71bps in 2023 and later grew 13bps in 2024.
  • Arcus Biosciences' Return on Invested Capital stood at 0.08% in 2021, then plummeted by -652bps to 0.41% in 2022, then plummeted by -70bps to 0.71% in 2023, then increased by 18bps to 0.58% in 2024, then dropped by -10bps to 0.64% in 2025.
  • The last three reported values for Return on Invested Capital were 0.64% (Q3 2025), 0.55% (Q2 2025), and 0.79% (Q1 2025) per Business Quant data.